Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 14/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.64 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.64 |
| ▸ | PGR | P06401 | 5/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.64 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.64 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.64 |
| ▸ | AR | P10275 | 2/20 | 0.64 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.64 |
| ▸ | TNF | P01375 | 1/20 | 0.64 |
| ▸ | IL6 | P05231 | 1/20 | 0.64 |
| ▸ | GLUL | P15104 | 1/20 | 0.64 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.64 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | SHBG | P04278 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL945988 | 0.99 | HIF1A (0.65) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL704875 | 0.97 | HIF1A (0.61) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL7095395 | 0.96 | HIF1A (0.61) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL27748218 | 0.96 | HIF1A (0.61) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL11068491 | 0.95 | HIF1A (0.62) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL27781029 | 0.95 | HIF1A (0.66) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL122048 | 0.94 | HIF1A (0.63) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL677626 | 0.94 | HIF1A (0.61) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL7999837 | 0.94 | HIF1A (0.57) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL22042713 | 0.94 | HIF1A (0.59) | HIF1AHSD17B10NR3C1PGRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4447988-B1 | COMPOSITIONS FOR TREATING AUTOIMMUNE ARTHRITIS | DEVINTEC SAGL (CH) | 2026-05-27 | — | — | EP | disclosed |
| US-20250134953-A1 | COMPOSITIONS FOR TREATING AUTOIMMUNE ARTHRITIS | DEVINTEC SAGL (CH) | 2025-05-01 | — | — | US | disclosed |
| US-20250127848-A1 | COMPOSITIONS FOR TREATING AUTOIMMUNE ARTHRITIS | DEVINTEC SAGL (CH) | 2025-04-24 | — | — | US | disclosed |
| US-12178844-B2 | Compositions for treating autoimmune arthritis | DEVINTEC SAGL (CH) | 2024-12-31 | — | — | US | disclosed |
| US-20240090555-A1 | EDIBLE MYCOPROTEIN PELLETS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-03-21 | — | — | US | disclosed |
| US-20240091308-A1 | COMPOSITIONS FOR TREATING AUTOIMMUNE ARTHRITIS | DEVINTEC SAGL (CH) | 2024-03-21 | — | — | US | disclosed |
| WO-2023110855-A1 | COMPOSITIONS FOR TREATING AUTOIMMUNE ARTHRITIS | DEVINTEC SAGL (CH) | 2023-06-22 | — | — | WO | disclosed |
| US-20230146925-A1 | DEPOT FORMULATIONS | DURECT CORPORATION (US) | 2023-05-11 | — | — | US | disclosed |
| CN-115645399-A | Long-acting formulations | 度瑞公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-109602692-B | Injectable controlled release compositions comprising high viscosity liquid carriers | 度瑞公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-1006935-A4 | HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM | SOUTHERN BIOSYSTEMS INC (US) | 2001-05-02 | — | — | EP | disclosed |
| WO-2001015734-A2 | HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM AND MEDICAL OR SURGICAL DEVICE | SOUTHERN BIOSYSTEMS, INC. (US) | 2001-03-08 | — | — | WO | disclosed |
| WO-2000066087-A2 | EMULSION-BASED PROCESSES FOR MAKING MICROPARTICLES | SOUTHERN BIOSYSTEMS, INC. (US) | 2000-11-09 | — | — | WO | disclosed |
| EP-1015032-A2 | HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM AS A DEVICE | Southern Biosystems, Inc. (US) | 2000-07-05 | — | — | EP | disclosed |
| EP-1006935-A1 | HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM | Southern Biosystems, Inc. (US) | 2000-06-14 | — | — | EP | disclosed |
| US-5968542-A | SURGICAL IMPLANTS; NONCRYSTALLIZING CARRIER | SOUTHERN BIOSYSTEMS, INC. (US) | 1999-10-19 | — | — | US | disclosed |
| WO-1999013913-A2 | HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM AS A DEVICE | SOUTHERN BIOSYSTEMS, INC. (US) | 1999-03-25 | — | — | WO | disclosed |
| US-5747058-A | ACTIVE MATERIALS AND CARRIERS FOR CONTROLLED RELEASE SUBSTANCE | SOUTHERN BIOSYSTEMS, INC. (US) | 1998-05-05 | — | — | US | disclosed |
| WO-1996039995-A1 | HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM | SOUTHERN BIOSYSTEMS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-4178361-A | Sustained release pharmaceutical composition | UNION CORPORATION (US) | 1979-12-11 | — | — | US | disclosed |